An update on the latest Covid-19 news by DDW Digital Content Editor Diana Spencer
With winter around the corner and cases once again on the rise, the last few weeks have seen some interesting developments related to Covid-19. We found out that Omicron infection protects against flu, studies in potential treatments for severe Covid have shown promise, and new genetic insights into ME and CSF were revealed that could have implications in long Covid.
And in other virus news, researchers have discovered that a modified version of the herpes simplex virus showed signs of effectiveness in a range of advanced cancers.
The top stories:
The latest Omicron variants of Covid could be protective against serious influenza infection, a leading testing expert says.
A proof of concept (POC) study has shown the clinical benefit of zapnometinib in patients with severe Covid-19 and supports further evaluation in severe viral diseases.
A recent study by the University of Colorado School of Medicine shows that diabetes drug metformin is effective for preventing severe illness from Covid-19.
A new study has provided the first detailed genetic insights into the pathophysiological mechanisms underpinning Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
A new genetically engineered herpes virus has delivered a one-two punch against advanced cancers in initial findings from a Phase I trial.